Jordan I - Search Results

1

Expression of an Efficient Selection Marker Out of a Duplicated Site in the ITRs of a Modified Vaccinia Virus Ankara (MVA).

Abidi S, Elhazaz Fernandez A, Seehase N, Hanisch L, Karlas A, Sandig V, Jordan I. Abidi S, et al. Among authors: jordan i. Vaccines (Basel). 2024 Dec 6;12(12):1377. doi: 10.3390/vaccines12121377. Vaccines (Basel). 2024. PMID: 39772039 Free PMC article.

2

Cell lines from the Egyptian fruit bat are permissive for modified vaccinia Ankara.

Jordan I, Horn D, Oehmke S, Leendertz FH, Sandig V. Jordan I, et al. Virus Res. 2009 Oct;145(1):54-62. doi: 10.1016/j.virusres.2009.06.007. Epub 2009 Jun 18. Virus Res. 2009. PMID: 19540275 Free PMC article.

3

A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium.

Jordan I, Horn D, John K, Sandig V. Jordan I, et al. Viruses. 2013 Jan 21;5(1):321-39. doi: 10.3390/v5010321. Viruses. 2013. PMID: 23337383 Free PMC article.

4

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

Jordan I, Lohr V, Genzel Y, Reichl U, Sandig V. Jordan I, et al. Microorganisms. 2013 Nov 1;1(1):100-121. doi: 10.3390/microorganisms1010100. Microorganisms. 2013. PMID: 27694766 Free PMC article. Review.

5

A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA).

Jordan I, Horn D, Thiele K, Haag L, Fiddeke K, Sandig V. Jordan I, et al. Virol Sin. 2020 Apr;35(2):212-226. doi: 10.1007/s12250-019-00176-3. Epub 2019 Dec 12. Virol Sin. 2020. PMID: 31833037 Free PMC article.

6

Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages.

Neckermann P, Mohr M, Billmeier M, Karlas A, Boilesen DR, Thirion C, Holst PJ, Jordan I, Sandig V, Asbach B, Wagner R. Neckermann P, et al. Among authors: jordan i. Front Immunol. 2024 Feb 6;15:1338492. doi: 10.3389/fimmu.2024.1338492. eCollection 2024. Front Immunol. 2024. PMID: 38380318 Free PMC article.

7

Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses.

Jordan I, Sandig V. Jordan I, et al. BMC Proc. 2011 Nov 22;5 Suppl 8(Suppl 8):O1. doi: 10.1186/1753-6561-5-S8-O1. eCollection 2011. BMC Proc. 2011. PMID: 22373097 Free PMC article. No abstract available.

8

High-cell-density cultivations to increase MVA virus production.

Vázquez-Ramírez D, Genzel Y, Jordan I, Sandig V, Reichl U. Vázquez-Ramírez D, et al. Among authors: jordan i. Vaccine. 2018 May 24;36(22):3124-3133. doi: 10.1016/j.vaccine.2017.10.112. Epub 2018 Feb 9. Vaccine. 2018. PMID: 29433897 Free PMC article.

9

High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.

Vázquez-Ramírez D, Jordan I, Sandig V, Genzel Y, Reichl U. Vázquez-Ramírez D, et al. Among authors: jordan i. Appl Microbiol Biotechnol. 2019 Apr;103(7):3025-3035. doi: 10.1007/s00253-019-09694-2. Epub 2019 Feb 23. Appl Microbiol Biotechnol. 2019. PMID: 30796494 Free PMC article.

10

Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine.

Göbel S, Kazemi O, Ma J, Jordan I, Sandig V, Paulissen J, Kerstens W, Thibaut HJ, Reichl U, Dallmeier K, Genzel Y. Göbel S, et al. Among authors: jordan i. Vaccines (Basel). 2024 Jul 9;12(7):755. doi: 10.3390/vaccines12070755. Vaccines (Basel). 2024. PMID: 39066393 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

549 results

Search Page

Filters